Repair Biotechnologies
Organization Description
Repair Biotechnologies develops the Cholesterol Degrading Platform (CDP), a first in class approach to therapy aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.
Team
Mourad Topors, Ph.D.
Repair Biotechnologies - Chief Scientific Officer
Reason
Repair Biotechnologies - CEO
